OBJECTIVE: Two competing hypotheses suggest how adiposity may affect menopausal hot flashes. The "thin hypothesis" asserts that aromatization of androgens to estrogens in body fat should be associated with decreased hot flashes. Conversely, thermoregulatory models argue that body fat should be associated with increased hot flashes. The study objective was to examine associations between abdominal adiposity and hot flashes, including the role of reproductive hormones in these associations. DESIGN: The Study of Women's Health Across the Nation Heart Study (2001-2003) is an ancillary study to the Study of Women's Health Across the Nation, a community-based cohort study. Participants were 461 women (35% African American, 65% white) ages 45 to 58 years with an intact uterus and at least one ovary. Measures included a computed tomography scan to assess abdominal adiposity; reported hot flashes over the previous 2 weeks; and a blood sample for measurement of follicle-stimulating hormone, estradiol, and sex hormone-binding globulin-adjusted estradiol (free estradiol index). Associations were evaluated within multivariable logistic and linear regression models. RESULTS: Every 1-SD increase in total (odds ratio [OR]=1.28; 95% CI: 1.06-1.55) and subcutaneous (OR=1.30; 95% CI: 1.07-1.58) abdominal adiposity was associated with increased odds of hot flashes in age- and site-adjusted models. Visceral adiposity was not associated with hot flashes. Associations were not reduced when models included reproductive hormone concentrations. CONCLUSION: Increased abdominal adiposity, particularly subcutaneous adiposity, is associated with increased odds of hot flashes, favoring thermoregulatory models of hot flashes. Body fat may not protect women from hot flashes as once thought.
OBJECTIVE: Two competing hypotheses suggest how adiposity may affect menopausal hot flashes. The "thin hypothesis" asserts that aromatization of androgens to estrogens in body fat should be associated with decreased hot flashes. Conversely, thermoregulatory models argue that body fat should be associated with increased hot flashes. The study objective was to examine associations between abdominal adiposity and hot flashes, including the role of reproductive hormones in these associations. DESIGN: The Study of Women's Health Across the Nation Heart Study (2001-2003) is an ancillary study to the Study of Women's Health Across the Nation, a community-based cohort study. Participants were 461 women (35% African American, 65% white) ages 45 to 58 years with an intact uterus and at least one ovary. Measures included a computed tomography scan to assess abdominal adiposity; reported hot flashes over the previous 2 weeks; and a blood sample for measurement of follicle-stimulating hormone, estradiol, and sex hormone-binding globulin-adjusted estradiol (free estradiol index). Associations were evaluated within multivariable logistic and linear regression models. RESULTS: Every 1-SD increase in total (odds ratio [OR]=1.28; 95% CI: 1.06-1.55) and subcutaneous (OR=1.30; 95% CI: 1.07-1.58) abdominal adiposity was associated with increased odds of hot flashes in age- and site-adjusted models. Visceral adiposity was not associated with hot flashes. Associations were not reduced when models included reproductive hormone concentrations. CONCLUSION: Increased abdominal adiposity, particularly subcutaneous adiposity, is associated with increased odds of hot flashes, favoring thermoregulatory models of hot flashes. Body fat may not protect women from hot flashes as once thought.
Authors: Maura K Whiteman; Catherine A Staropoli; Patricia W Langenberg; Robert J McCarter; Kristen H Kjerulff; Jodi A Flaws Journal: Obstet Gynecol Date: 2003-02 Impact factor: 7.661
Authors: Joyce T Bromberger; Susan F Assmann; Nancy E Avis; Miriam Schocken; Howard M Kravitz; Adriana Cordal Journal: Am J Epidemiol Date: 2003-08-15 Impact factor: 4.897
Authors: Howard M Kravitz; Patricia A Ganz; Joyce Bromberger; Lynda H Powell; Kim Sutton-Tyrrell; Peter M Meyer Journal: Menopause Date: 2003 Jan-Feb Impact factor: 2.953
Authors: Bret H Goodpaster; Shanthi Krishnaswami; Helaine Resnick; David E Kelley; Catherine Haggerty; Tamara B Harris; Ann V Schwartz; Steven Kritchevsky; Anne B Newman Journal: Diabetes Care Date: 2003-02 Impact factor: 19.112
Authors: Jacques E Rossouw; Garnet L Anderson; Ross L Prentice; Andrea Z LaCroix; Charles Kooperberg; Marcia L Stefanick; Rebecca D Jackson; Shirley A A Beresford; Barbara V Howard; Karen C Johnson; Jane Morley Kotchen; Judith Ockene Journal: JAMA Date: 2002-07-17 Impact factor: 56.272
Authors: Melinda L Irwin; Yutaka Yasui; Cornelia M Ulrich; Deborah Bowen; Rebecca E Rudolph; Robert S Schwartz; Michi Yukawa; Erin Aiello; John D Potter; Anne McTiernan Journal: JAMA Date: 2003-01-15 Impact factor: 56.272
Authors: Lisa Gallicchio; Susan R Miller; Judith Kiefer; Teresa Greene; Howard A Zacur; Jodi A Flaws Journal: J Womens Health (Larchmt) Date: 2013-12-17 Impact factor: 2.681
Authors: Patricia G Moorman; Joellen M Schildkraut; Evan R Myers; Frances Wang Journal: J Womens Health (Larchmt) Date: 2011-06-14 Impact factor: 2.681
Authors: Ping G Tepper; Maria M Brooks; John F Randolph; Sybil L Crawford; Samar R El Khoudary; Ellen B Gold; Bill L Lasley; Bobby Jones; Hadine Joffe; Rachel Hess; Nancy E Avis; Sioban Harlow; Daniel S McConnell; Joyce T Bromberger; Huiyong Zheng; Kristine Ruppert; Rebecca C Thurston Journal: Menopause Date: 2016-10 Impact factor: 2.953
Authors: Lisa Gallicchio; Susan R Miller; Judith Kiefer; Teresa Greene; Howard A Zacur; Jodi A Flaws Journal: Menopause Date: 2015-10 Impact factor: 2.953
Authors: Bette J Caan; Jennifer A Emond; H Irene Su; Ruth E Patterson; Shirley W Flatt; Ellen B Gold; Vicky A Newman; Cheryl L Rock; Cynthia A Thomson; John P Pierce Journal: J Clin Oncol Date: 2012-03-19 Impact factor: 44.544
Authors: Ayelet Ziv-Gal; Lisa Gallicchio; Susan R Miller; Howard A Zacur; Jodi A Flaws Journal: Am J Obstet Gynecol Date: 2012-06-01 Impact factor: 8.661
Authors: Alexis Nasr; Karen A Matthews; Maria M Brooks; Daniel S McConnell; Trevor J Orchard; Jeffrey Billheimer; Daniel J Rader; Samar R El Khoudary Journal: J Clin Lipidol Date: 2020-07-08 Impact factor: 4.766